AR051145A1 - Composiciones analgesicas / antipireticas para absorcion potenciada - Google Patents
Composiciones analgesicas / antipireticas para absorcion potenciadaInfo
- Publication number
- AR051145A1 AR051145A1 ARP050104491A ARP050104491A AR051145A1 AR 051145 A1 AR051145 A1 AR 051145A1 AR P050104491 A ARP050104491 A AR P050104491A AR P050104491 A ARP050104491 A AR P050104491A AR 051145 A1 AR051145 A1 AR 051145A1
- Authority
- AR
- Argentina
- Prior art keywords
- analgesic
- composition
- antipiretic
- potentiated
- absorption
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 230000000202 analgesic effect Effects 0.000 title abstract 5
- 238000010521 absorption reaction Methods 0.000 title 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 2
- 239000002221 antipyretic Substances 0.000 abstract 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960005489 paracetamol Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62281204P | 2004-10-28 | 2004-10-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR051145A1 true AR051145A1 (es) | 2006-12-20 |
Family
ID=35744599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050104491A AR051145A1 (es) | 2004-10-28 | 2005-10-26 | Composiciones analgesicas / antipireticas para absorcion potenciada |
Country Status (17)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0607085D0 (en) | 2006-04-07 | 2006-05-17 | Smithkline Beecham Corp | Novel compositions |
| CN100417385C (zh) * | 2006-09-26 | 2008-09-10 | 林星 | 一种用于治疗外伤的外用制剂 |
| GB0707489D0 (en) * | 2007-04-18 | 2007-05-23 | Renaissance Pharma | Compounds |
| CN101596163B (zh) * | 2008-06-06 | 2012-06-27 | 康美保宁(四川)制药有限公司 | 阿咖酚微丸制剂及其制备方法 |
| GB0813929D0 (en) * | 2008-07-30 | 2008-09-03 | Glaxo Group Ltd | Novel method |
| CN102861040B (zh) * | 2012-08-02 | 2014-04-23 | 广东环球制药有限公司 | 含有阿司匹林、对乙酰氨基酚和咖啡因的药物组合物及其制备方法 |
| CN102949401A (zh) * | 2012-09-06 | 2013-03-06 | 广东九明制药有限公司 | 对乙酰氨基酚、乙酰水杨酸和咖啡因组合物及其制备工艺 |
| US10124005B1 (en) * | 2017-12-15 | 2018-11-13 | Lisa Josette Myslinski | Multisymptom migraine combination medication |
| CN110711197B (zh) * | 2018-07-12 | 2023-11-24 | 北京恒润泰生医药科技有限公司 | 阿司匹林和对乙酰氨基酚的分子复合物加咖啡因,其制备,活性及应用 |
| CN108853124A (zh) * | 2018-08-15 | 2018-11-23 | 康美保宁(四川)制药有限公司 | 一种阿咖酚制剂及其制剂方法 |
| GB202007670D0 (en) * | 2020-05-22 | 2020-07-08 | Glaxosmithkline Consumer Healthcare Holdings Us Llc | Pharmaceutical composition |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4294819A (en) * | 1980-08-18 | 1981-10-13 | Bristol-Myers Company | Alkaline analgesic capsule |
| CA1182049A (en) * | 1981-07-13 | 1985-02-05 | Francis J. Sterbenz | Apap antacid composition |
| US5296241A (en) * | 1991-04-03 | 1994-03-22 | Brimberg Barnett J | Therapeutic composition and method of using same for treatment of hangover |
| JP3122748B2 (ja) * | 1991-11-29 | 2001-01-09 | ライオン株式会社 | イブプロフェン含有解熱鎮痛剤 |
| JP3172749B2 (ja) * | 1992-02-17 | 2001-06-04 | ライオン株式会社 | イブプロフェン含有製剤 |
| JPH06227995A (ja) * | 1993-02-03 | 1994-08-16 | Takeda Chem Ind Ltd | 安定化された固型製剤 |
| JPH07206689A (ja) * | 1994-01-21 | 1995-08-08 | Barnett Lab Ltd | 治療組成物および宿酔の治療のためのこの組成物の使用法 |
| DE19502789A1 (de) * | 1995-01-28 | 1996-08-01 | Dirk Krischenowski | Arzneimittel |
| RU2101014C1 (ru) * | 1995-09-07 | 1998-01-10 | Акционерное общество "Курский комбинат лекарственных средств" | Анальгезирующее, противовоспалительное, жаропонижающее лекарственное средство и способ его получения |
| GB9704524D0 (en) * | 1997-03-05 | 1997-04-23 | Smithkline Beecham Plc | Composition |
| US5972916A (en) * | 1997-07-14 | 1999-10-26 | Bristol-Myers Squibb Company | Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine |
| JP2002012557A (ja) * | 2000-06-28 | 2002-01-15 | Lion Corp | 内服薬組成物 |
| US20040147606A1 (en) * | 2001-05-25 | 2004-07-29 | Yoichi Onuki | Medicinal compositions |
| JP4553552B2 (ja) * | 2003-01-08 | 2010-09-29 | 日東薬品工業株式会社 | 生体リズム応用キット |
-
2005
- 2005-10-26 AU AU2005302618A patent/AU2005302618B2/en not_active Expired
- 2005-10-26 MX MX2007005121A patent/MX2007005121A/es active IP Right Grant
- 2005-10-26 JP JP2007539060A patent/JP2008518914A/ja active Pending
- 2005-10-26 EP EP05821186A patent/EP1807068B1/en not_active Expired - Lifetime
- 2005-10-26 WO PCT/US2005/038507 patent/WO2006049978A1/en not_active Ceased
- 2005-10-26 AR ARP050104491A patent/AR051145A1/es not_active Application Discontinuation
- 2005-10-26 DE DE602005020048T patent/DE602005020048D1/de not_active Expired - Lifetime
- 2005-10-26 CN CNA2005800370243A patent/CN101048155A/zh active Pending
- 2005-10-26 PE PE2005001253A patent/PE20061125A1/es not_active Application Discontinuation
- 2005-10-26 RU RU2007119641/15A patent/RU2398571C2/ru not_active IP Right Cessation
- 2005-10-26 CA CA2583517A patent/CA2583517C/en not_active Expired - Fee Related
- 2005-10-26 US US11/666,528 patent/US20070298096A1/en not_active Abandoned
- 2005-10-26 PL PL05821186T patent/PL1807068T3/pl unknown
- 2005-10-26 BR BRPI0520000-8A patent/BRPI0520000A2/pt not_active IP Right Cessation
- 2005-10-26 AT AT05821186T patent/ATE460930T1/de not_active IP Right Cessation
- 2005-10-26 PT PT05821186T patent/PT1807068E/pt unknown
-
2007
- 2007-05-02 NO NO20072255A patent/NO20072255L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PT1807068E (pt) | 2010-04-19 |
| US20070298096A1 (en) | 2007-12-27 |
| EP1807068B1 (en) | 2010-03-17 |
| BRPI0520000A2 (pt) | 2009-04-07 |
| PE20061125A1 (es) | 2006-11-08 |
| AU2005302618A1 (en) | 2006-05-11 |
| RU2007119641A (ru) | 2008-12-10 |
| RU2398571C2 (ru) | 2010-09-10 |
| EP1807068A1 (en) | 2007-07-18 |
| ATE460930T1 (de) | 2010-04-15 |
| WO2006049978A1 (en) | 2006-05-11 |
| MX2007005121A (es) | 2007-06-22 |
| CA2583517A1 (en) | 2006-05-11 |
| AU2005302618B2 (en) | 2009-10-22 |
| CA2583517C (en) | 2013-06-04 |
| CN101048155A (zh) | 2007-10-03 |
| PL1807068T3 (pl) | 2010-08-31 |
| DE602005020048D1 (de) | 2010-04-29 |
| JP2008518914A (ja) | 2008-06-05 |
| NO20072255L (no) | 2007-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR049083A1 (es) | Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso | |
| MX2007000564A (es) | Metodo para utilizar efectivamente medicamentos referentes a la prevencion de efectos secundarios. | |
| AR061772A1 (es) | Composicion de alto contenido de ion fluoruro para el cuidado oral y metodo para mantener la actividad anticaries | |
| DOP2012000245A (es) | Composiciones sólidas | |
| AR109263A2 (es) | Composición que comprende moxidectina | |
| BRPI0514474A (pt) | multiparticulados | |
| UY28509A1 (es) | Formas de dosificacion de azitromicina con efectos secundarios reducidos | |
| ES2422217T3 (es) | Concentrado de espuma para apagar incendios | |
| ECSP088422A (es) | Composiciones farmacéuticas sólidas que contienen pregabalina | |
| AR040302A1 (es) | Dispositivos para la liberacion transdermica de farmacos, que presentan microprotrusiones recubiertas | |
| CL2012001019A1 (es) | Composicion farmaceutica que comprende una proenzima de proteasa seleccionada de al menos tripsinogeno y quimiotripsinogeno y un agente activo seleccionado de al menos un compuesto de selenio, un compuesto vanilloide, un agente reductor de glicolisis citoplasmica y opcionalmente una glucosidohidrolasa; y uso para tratar cancer. | |
| ES2487496T3 (es) | Agente para aliviar el síndrome metabólico | |
| CL2012000374A1 (es) | Metodo para la preparacion de una composicion saborizante activa que comprende una primera reaccion entre un compuesto amino y un carbonilo, resultando una primera mezcla de intermediarios, una segunda reaccion con un segundo compuesto amino solo o en combinacion con un compuesto carbinilo, resultando una segunda mezcla de intermediarios, reacciones serparadas adicionales con compuestos de otras clases quimicas, ultima reaccion que comprende una mezcla de todas las mezclas de intermediarios anteriores. | |
| AR072685A1 (es) | Composicion topica para el tratamiento de queratosis actinica | |
| BR0317924A (pt) | Formas de dosagem não aquosas de composto de prostaglandina e | |
| AR060264A1 (es) | Composicion farmaceutica que contiene lactato y calcio, usos de dicha composicion y metodo de preparacion | |
| BRPI0417672A (pt) | processos para produzir composições de vìrus estáveis em armazenamento, composições de vìrus e imunogênicas | |
| GT200600023A (es) | Combinacion de xolair con agente inmunosupresivo | |
| UY27727A1 (es) | Nueva composicion farmacéutica- | |
| ATE420918T1 (de) | Sauerstoffbarriereformulierungen | |
| MX2007005121A (es) | Composicion que comprende acetaminofen, cafeina y opcionalmente aspirina junto con un agente alcalino para mejorar la absorcion. | |
| UY28148A1 (es) | Bromhidrato de escitalopram y un metodo para su preparacion | |
| AR051385A1 (es) | Agentes de curtido a base de isocianato | |
| AR056500A1 (es) | Metodo para preparar una composicion medica | |
| AR065068A1 (es) | Composicion farmaceutica que comprende tramadol y ketoprofeno en asociacion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |